SEC Form 4 · accession 0001209191-18-058715
QUAKER CHEMICAL CORP · KWR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dieter Laininger
Officer — VP & MD - A/P & SA & PRI MTLS
Period of report
Nov 13, 2018
Accepted (ET)
Nov 15, 2018 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000081362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 13, 2018 | S | 1,000 | $200.00 | D | 6,106 | D | |
| Common Stock | Nov 13, 2018 | S | 500 | $202.00 | D | 5,606 | D | |
| Common Stock | Nov 14, 2018 | S | 1,000 | $202.00 | D | 4,606 | D | |
| Common Stock | Nov 15, 2018 | M | 744 | $87.30 | A | 5,350 | D | |
| Common StockF2 | Nov 15, 2018 | S | 744 | $202.3026 | D | 4,606 | D | |
| Common Stock | Nov 15, 2018 | M | 1,213 | $72.12 | A | 5,819 | D | |
| Common StockF3 | Nov 15, 2018 | S | 1,213 | $202.7881 | D | 4,606 | D | |
| Common Stock | Nov 15, 2018 | M | 730 | $134.60 | A | 5,336 | D | |
| Common StockF4 | Nov 15, 2018 | S | 553 | $203.4152 | D | 4,783 | D | |
| Common StockF5 | Nov 15, 2018 | S | 177 | $204.3645 | D | 4,606 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F6 | $87.30 | Nov 15, 2018 | M | 744 | D | — | Feb 25, 2022 | Common Stock | 744 | 0 | D |
| Employee Stock Option (right to buy)F7 | $72.12 | Nov 15, 2018 | M | 1,213 | D | — | Feb 23, 2023 | Common Stock | 1,213 | 1,213 | D |
| Employee Stock Option (right to buy)F8 | $134.60 | Nov 15, 2018 | M | 730 | D | — | Feb 27, 2024 | Common Stock | 730 | 1,458 | D |
Explanation of responses
- F1Includes 2 shares acquired by reporting person under the Company's Dividend Reinvestment Plan on April 30, 2018.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.00 to $202.5250, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.5250 to $203.04, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.04 to $203.78, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.36 to $204.44, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
- F6The options for this grant vested in three annual installments: 745 shares on February 25, 2016; 744 shares on February 25, 2017; and 744 shares on February 25, 2018.
- F7The options for this grant vest in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.
- F8The options for this grant vest in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020.